Stockholm - Delayed Quote SEK

Genovis AB (publ.) (GENO.ST)

25.40
-0.25
(-0.97%)
At close: 5:29:49 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
130,358
130,358
158,232
102,387
93,017.54
Cost of Revenue
--
15,387
15,160
15,018
11,728.57
Gross Profit
114,971
114,971
143,072
87,369
81,288.97
Operating Expense
69,239
69,239
88,197
73,548
58,180.93
Operating Income
--
45,732
54,875
13,821
23,108.04
Net Non Operating Interest Income Expense
500
500
626
-281
60.33
Pretax Income
46,329
46,329
54,850
7,996
24,603.65
Tax Provision
13,413
13,413
-6,650
-3,195
-173.74
Net Income Common Stockholders
32,916
32,916
61,500
11,191
24,777.39
Diluted NI Available to Com Stockholders
32,916
32,916
61,500
11,191
24,777.39
Basic EPS
0.50
--
0.94
0.17
0.38
Diluted EPS
0.50
--
0.94
0.17
0.38
Basic Average Shares
65,465.71
--
65,465.71
65,465.71
65,465.71
Diluted Average Shares
65,465.71
--
65,465.71
65,465.71
65,465.71
Total Operating Income as Reported
45,732
45,732
54,224
8,277
24,543.32
Total Expenses
84,626
84,626
103,357
88,566
69,909.50
Net Income from Continuing & Discontinued Operation
32,916
32,916
61,500
11,191
24,777.39
Normalized Income
32,916
32,916
61,500
18,236.96
24,721.77
Interest Income
--
--
2,890
57
--
Interest Expense
--
--
2,264
338
--
Net Interest Income
500
500
626
-281
60.33
EBIT
45,732
45,732
57,114
8,334
23,108.04
EBITDA
50,860
56,178
66,836
14,966
28,879.08
Reconciled Cost of Revenue
15,387
15,387
15,160
15,018
11,728.57
Reconciled Depreciation
10,446
10,446
9,722
6,632
5,771.04
Net Income from Continuing Operation Net Minority Interest
32,916
32,916
61,500
11,191
24,777.39
Total Unusual Items Excluding Goodwill
--
--
0
-8,874
70.04
Total Unusual Items
--
--
0
-8,874
70.04
Normalized EBITDA
35,935
56,178
66,836
23,840
28,809.04
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5,244.30
0
0
-1,828.04
14.43
12/31/2021 - 6/2/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LIDDS.ST LIDDS AB (publ)
0.0320
-21.95%
 
IMMU.ST Mendus AB (publ)
4.8450
-2.61%
 
QUIA.ST Quia Pharma AB (publ)
0.0074
-8.64%
 
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
2.0500
0.00%
 
GUARD.ST Guard Therapeutics International AB (publ)
15.55
+1.63%
 
NANECH.ST NanoEcho AB
0.1030
-5.33%
 
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0958
+0.21%
 
XINT.ST Xintela AB (publ)
0.4800
-2.83%
 
ALZ.ST Alzinova AB (publ)
1.7500
-2.67%
 
2CUREX.ST 2cureX AB (publ)
2.0000
+3.09%